Waldencast plc (NASDAQ: WALD) announced that the U.S. Securities and Exchange Commission has concluded its investigation into the company’s restatement of financial results and material weaknesses in internal controls over financial reporting. The investigation, which began after the company voluntarily disclosed accounting issues related to Obagi Cosmeceuticals, ended on April 28, 2026, with the SEC stating it will not recommend enforcement action against Waldencast.
The investigation focused on the company’s restatement of financial results and identified material weaknesses in its internal control over financial reporting. The issues were linked to accounting practices at Obagi Cosmeceuticals, a key brand within Waldencast’s portfolio. The SEC’s decision to forego enforcement action indicates that the agency found no evidence of willful misconduct or violations that would warrant penalties.
Waldencast reported that it incurred substantial legal and advisory costs during the investigation. The company emphasized that it fully cooperated with the SEC and dedicated significant resources to the process, a commitment that helped expedite the resolution of the inquiry.
"We are pleased with the favorable outcome of the SEC's investigation. Throughout the Investigation, we fully cooperated and dedicated significant resources to the process. At the same time, we maintained our focus on executing our business plans, upholding strong governance, and ensuring robust internal controls," said CEO Michel Brousset.
The conclusion of the investigation removes a significant regulatory overhang that had weighed on investor confidence. With the SEC’s findings cleared, Waldencast can now concentrate on its core business operations, brand development, and strategic initiatives. However, the company remains a deep turnaround story, reporting approximately $272.1 million in revenue and a pretax profit margin near –125%. A large portion of its assets is tied up in goodwill and intangibles from acquisitions such as Obagi Cosmeceuticals, underscoring ongoing financial challenges.
Investors welcomed the news, recognizing that the removal of the regulatory cloud allows a clearer assessment of Waldencast’s business prospects. Nonetheless, the company’s financial performance and balance‑sheet profile continue to present headwinds that will require sustained focus on cost control, operational efficiency, and strategic growth to achieve profitability.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.